Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Dabigatran: a new therapeutic option for therapy and prophylaxis of thromboembolic diseases?].

Deutsche medizinische Wochenschrift (1946)·2010
Same author

[Guideline based diagnosis and therapy can improve medical standards].

Deutsche medizinische Wochenschrift (1946)·2010
Same author

Pioglitazone and mechanisms of CV protection.

QJM : monthly journal of the Association of Physicians·2009
Same author

[Elevation of the ST segment and positive troponin T as a sign of myocardial damage in acute stroke].

Deutsche medizinische Wochenschrift (1946)·2009
Same author

[Preventive cardiology: from prevention to optimal patient care].

Deutsche medizinische Wochenschrift (1946)·2009
Same author

[Ankle-brachial index].

Deutsche medizinische Wochenschrift (1946)·2009

Related Experiment Video

Updated: May 13, 2026

Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training
09:57

Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training

Published on: January 18, 2021

[What does individualized medicine mean today?]

E Erdmann

    Deutsche Medizinische Wochenschrift (1946)
    |March 21, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
    07:46

    Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

    Published on: April 30, 2021

    Related Experiment Videos

    Last Updated: May 13, 2026

    Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training
    09:57

    Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training

    Published on: January 18, 2021

    Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
    07:46

    Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

    Published on: April 30, 2021